WCN25-4053 A CASE SERIES OF POST TRANSPLANT - PARVOVIRUS B19 INDUCED ANAEMIA TREATED WITH NOVEL HIF-PHI: DESIDUSTAT
Saved in:
| Main Authors: | Sreedhar CG, Athish M N, Kishan A, Mythri S, Anusha V, Kallappa B, Keerthi K, Sairam B, Prasanna B, Ankita R |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924030006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Redefining anaemia management in CKD: comparative insights on desidustat, roxadustat, and molidustat as oral HIF-PH inhibitors
by: Kaandeeban Mohanraj, et al.
Published: (2025-07-01) -
WCN25-2356 REAL WORLD EXPERIENCE OF HIF-PHI – DESIDUSTAT (OXEMIA®) IN DIALYSIS AND NON-DIALYSIS DEPENDENT CKD ANEMIA PATIENTS
by: Vijay Sinha, et al.
Published: (2025-02-01) -
WCN25-2264 ONE-YEAR RETROSPECTIVE ANALYSIS OF DESIDUSTAT: A PROMISING HIF-PHI FOR ANEMIA MANAGEMENT IN DIALYSIS-DEPENDENT CKD PATIENTS
by: Rajeev Kumar Bhatia, et al.
Published: (2025-02-01) -
WCN25-2509 GENETIC VARIANTS ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) IN AN INDIAN POPULATION
by: Mythri Shankar, et al.
Published: (2025-02-01) -
Progress of HIF-1α and HIF-PHI in vascular calcification of chronic kidney disease
by: WANG Ao, et al.
Published: (2024-08-01)